aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001564590-18-021715
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$10.41M | -$12.14M | -$15.38M | -$11.08M |
| EPS Diluted | -$4.88 | -$0.51 | -$0.65 | -$0.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end
